A Zantac Resume of Recalls
12/30/2020
In June of 2020, Zantac released its findings to the FDA after conducting its own investigation. The company had conducted an internal investigation and a survey of its manufacturing plant and found some irregularities. In June, it announced that it would file a report to the FDA. In September, the company released its results of that internal investigation to the FDA. This is when it revealed three separate cases of potential hazard from the use of Zantac and two class action lawsuits filed by consumers who bought Zantac and were injured.
A Zantac Pharmaceuticals representative offered a statement to reporters on the results of the company's internal investigation into the causes of these recalled products. The pharmaceutical giant plans to voluntarily recall all of the Zantac ointments, powders and oral supplements it has developed since April of 2020. In addition, Zantac is working with the Food and Drug Administration to ensure that all of its employees are aware of this recall and are required to report any symptoms that come from this medication within twenty-four hours. Go to https://zantacsettlement.org for options on pharma recalls now.
In addition to this, Zantac is also recalling two other common prescription drugs, name and ndapredine. These are both considered to be higher strength than Zantac, and as such have a higher risk for causing overdose and/or severe adverse reactions. The recalled drugs were sold in the following combination: Zantac, methylphenidate hydrochloride, name, hydroxybutynin and dapoxetine hydrochloride. It is believed that patients who took this combination in high doses would be at increased risk of experiencing adverse events. Those patients should stop taking the products immediately and contact their doctor or pharmacist for further information about this Zantac recall.
A Zantac Pharmaceuticals representative offered a statement to reporters on the results of the company's internal investigation into the causes of these recalled products. The pharmaceutical giant plans to voluntarily recall all of the Zantac ointments, powders and oral supplements it has developed since April of 2020. In addition, Zantac is working with the Food and Drug Administration to ensure that all of its employees are aware of this recall and are required to report any symptoms that come from this medication within twenty-four hours. Go to https://zantacsettlement.org for options on pharma recalls now.
In addition to this, Zantac is also recalling two other common prescription drugs, name and ndapredine. These are both considered to be higher strength than Zantac, and as such have a higher risk for causing overdose and/or severe adverse reactions. The recalled drugs were sold in the following combination: Zantac, methylphenidate hydrochloride, name, hydroxybutynin and dapoxetine hydrochloride. It is believed that patients who took this combination in high doses would be at increased risk of experiencing adverse events. Those patients should stop taking the products immediately and contact their doctor or pharmacist for further information about this Zantac recall.